SIMPLEX TRADING, LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
319
-96.6%
0.00%
Q2 2023$44
-24.1%
9,441
-8.7%
0.00%
Q1 2023$58
+286.7%
10,336
+587.2%
0.00%
Q4 2022$15
-100.0%
1,504
+10.2%
0.00%
Q3 2022$30,000
+650.0%
1,365
+689.0%
0.00%
Q2 2022$4,000
-99.0%
173
-98.3%
0.00%
Q1 2022$403,000
+1579.2%
10,417
+2345.3%
0.00%
Q4 2021$24,000
-96.9%
426
-97.8%
0.00%
-100.0%
Q3 2020$770,000
+2466.7%
19,284
+1121.3%
0.00%
Q4 2019$30,000
-81.4%
1,579
-84.8%
0.00%
Q3 2019$161,000
-25.8%
10,388
-3.2%
0.00%
-100.0%
Q2 2019$217,000
-32.8%
10,730
-41.7%
0.00%0.0%
Q1 2019$323,000
+201.9%
18,413
+119.4%
0.00%
Q4 2018$107,000
+10600.0%
8,394
+7263.2%
0.00%
Q3 2018$1,000
-99.3%
114
-99.1%
0.00%
-100.0%
Q2 2018$149,000
-48.1%
13,165
-55.3%
0.00%
-92.3%
Q1 2018$287,000
+1095.8%
29,462
+637.7%
0.01%
+1200.0%
Q4 2017$24,0003,994
+3740.4%
0.00%
Q3 2017$01040.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 2,073,190$26,599,00026.59%
Polaris Venture Management Co. V, L.L.C. 1,823,186$23,391,00024.97%
Casdin Capital, LLC 2,550,000$32,717,0005.60%
Redmile Group, LLC 10,359,666$132,915,0005.34%
Aquilo Capital Management, LLC 697,096$8,944,0004.33%
Eversept Partners, LP 165,000$2,116,9501.15%
Artal Group S.A. 2,150,000$27,585,0001.02%
AlpInvest Partners B.V. 26,925$345,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,654,865$21,232,0000.85%
Lisanti Capital Growth, LLC 142,760$1,832,0000.74%
View complete list of FATE THERAPEUTICS INC shareholders